Invicro
Subscribe to Industry Content

<< Back to Recent News

  • Events: Invicro at WMIC 2016

    BOSTON, MA (August 26, 2016) – Read more about our attendance at WMIC, including presentations by our team.  SEE MORE

  • Webinar: High-Throughput Three-Dimensional Tissue Imaging in the Bright-Field, Fluorescence and Nuclear Regimes | June 8 | 11am EST

    In this talk, Jack Hoppin, Invicro co-founder, focuses on the strengths and limitations of these emerging translational tomographic techniques and technologies and evaluates their application as imaging biomarker tools.

    Get access to the recorded webinar here.

  • Events: Invicro at SNMMI 2016

    BOSTON, MA (June 10, 2016) – Read more about our attendance at SNMMI, including presentations by our team.  SEE MORE

  • News: Invicro Featured in WMIS Video Contest

    BOSTON, MA (June 8, 2016) – Invicro is the proud winner of the 2015 WMIS “This is Our Lab” Contest.  Winners were featured in a video to showcase their work, and the final product has been released on the WMIS website.  SEE MORE

  • Event: Invicro Hosts Translational Imaging Symposium in Boston

    BOSTON, MA (May 12, 2016) Leaders in translational molecular imaging will be presenting on the latest innovations and emerging global trends in the field. We look forward to hosting another event which will provide a forum for thought-leaders in translational imaging to share insights into the latest advancements in the field. SEE MORE

  • News: AXT Brings Invicro’s Preclinical Medical Imaging Products to Australia

    BOSTON, MA (April 5, 2016) AXT has recently bolstered their preclinical and translational imaging products portfolio with the addition of Invicro’s innovative software platforms. SEE MORE

  • News: Invicro Acquires Molecular NeuroImaging (MNI) to Establish Full Spectrum Translational Imaging Capabilities

    BOSTON, MA (February 25, 2016) – Invicro, LLC, and Molecular NeuroImaging, LLC, both leading providers of imaging service solutions and analysis software for research and drug development, announced they will merge all activities to provide the most comprehensive set of imaging services across the spectrum of drug development. Invicro has acquired MNI and MNI will operate as a division of Invicro. SEE MORE

  • News: Invicro UK launches MIAKAT™ – software package for the quantitative analysis of PET neuroimaging data — Invicro

    SEE MORE

  • Publications: Invicro Scientific Presentations at WMIC 2015

    Abstracts:

    Cryoflourescence Tomography (CFT) is an Ex Vivo Tool to Study Anatomy, Physiology, and Drug or Tracer Distribution in Brain and Other Organs SEE MORE

  • Events: Invicro at the 2015 World Molecular Imaging Congress

    BOSTON, MA (September 29, 2015) – Five Invicro teammates were pleased to attend September’s World Molecular Imaging Congress and continued to focus on fostering industry and academia relations… SEE MORE

  • News: Invicro Expands Preclinical Histology Service Capabilities with the Opening of Invicro Seattle

    Invicro expands 2D/3D histology imaging and analysis services for research and drug development  

    BOSTON, MA (March 20, 2015) – Invicro announced today its expansion of histology capabilities with the acquisition of a Seattle-based histology team and the opening of Invicro Seattle. SEE MORE

    • Software Release: Introducing VivoQuant® 2.0

      BOSTON, MA (February 25, 2015) – Invicro is excited to announce the release of VivoQuant® 2.0! Based on the valuable feedback of our customers, we have improved VivoQuant®’s user experience, making it more intuitive and even easier to interact with.  FUJIFILM VisualSonics Inc., a world leader in real-time, in vivo, high-resolution micro-imaging systems designed specifically for pre-clinical research and a subsidiary of FUJIFILM SonoSite, Inc, is pleased to announce a new and exclusive partnership with Invicro, LLC, and the development of the VisualSonics iPACS® Imaging Study Management System. SEE MORE

    • News: Invicro Expands Translational Imaging Capacity with Cyclotron Facility

      BOSTON, MA (May 26, 2015) – Born out of a strategic partnership between Invicro, MPI Research, and 3D Imaging, the TIC features the only industry-owned and -operated cyclotron facility with contiguous vivarium facilities in the world.  SEE MORE

    • Events: Governor Patrick Visits Invicro, Celebrates New Collaboration Stemming From Israel Trade Mission

      BOSTON, MA (December 1, 2014) – Last week Governor Deval Patrick visited Invicro, a fast-growing Boston life sciences firm, to join in announcing the company’s expanded development agreement with Israel-based Aspect Imaging.  SEE MORE

    • Events: Invicro to Host Translational Imaging Symposium Featuring Leading Imaging Scientists in Drug Development and Research

      BOSTON, MA (October 7, 2014) – Invicro, a leading provider of imaging service solutions and analysis software for drug discovery and development, will host its second Translational Imaging Symposium on Thursday October 9th at District Hall in Boston’s Innovation District. SEE MORE

    • News: Invicro’s Three Year Growth Rate of 687% Earns Second-Consecutive Appearance on Inc. Magazine’s 500 | 5000 list

      BOSTON, MA (September 2, 2014) – Invicro recognized as one of the top 700 fastest growing private companies in the United States and No. 20 in Boston metro area  SEE MORE

    • News: Jack Hoppin, Ph.D., Co-Founder and Managing Director of Invicro, LLC, joins the Board of Trustees of the WMIS

      BOSTON, MA (August 26, 2014) – Invicro is pleased to announce the selection of co-founder and Managing Director Jack Hoppin, Ph.D., to the Board of Trustees of the World Molecular Imaging Society (WMIS). SEE MORE

    • News: Translational Imaging Center to Speed Drug Development, Lower Costs

      Mattawan, MI (February 4, 2014) – MPI Research, Invicro, and 3D Imaging today formally announced the name of their new advanced imaging center being built at the MPI Research headquarters in Mattawan, Michigan.  SEE MORE

    • News: INVICRO named the 327th fastest growing company and 20th in the top 100 Health Companies

      Boston, MA (August 22, 2013) – Invicro, LLC, a leading imaging services and software organization, has been named the 327th fastest growing company in the USA according to the Inc. Magazine 5000 list released this week. SEE MORE

    • News: INVICRO, MPI Research, and 3D Imaging Announce Strategic Partnership

      BOSTON, MA (June 14, 2013)– Invicro, an industry-leading imaging software and contract research organization, is pleased to announce a strategic partnership with MPI Research and 3D Imaging to unite world-class molecular imaging, radiochemistry, and informatics to accelerate drug discovery and development. SEE MORE

    Contact the Author:

    Amanda Harrell | T. +1 215-644-3409 | E. aharrell@invicro.com

    Watch our latest Webinar!

    Cryofluorescence Tomography: A 3D Imaging Modality and its Applications in Drug Discovery

    Cryofluorescence Tomography: A 3D Imaging Modality and its Applications in Drug Discovery
    In this webinar, we demonstrated Cryoflourescence Tomography (CFT) and showed its applications to drug discovery. CFT is an ex vivo fluorescence imaging modality in which serial sectioning and blockface image acquisition is conducted throughout the sample.

    – Click for more information –

        Recent News Archived News Events Subscribe to Industry Content Contact Us Publications

        Contact Us:

        t: +1 617-904-2100 | info@invicro.com | 27 Drydock Avenue | Boston, MA 02210

        Our Policies

        FCOI Policy
        Privacy Statement

        Copyright (c) Invicro, LLC 2018